Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Provided By PR Newswire
Last update: Aug 28, 2025
HOLON, Israel, Aug. 28, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that management will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference.
Read more at prnewswire.com
